Mymetics Corporation (QB)
-0.00005 (-0.19%)
Volume 300,900
Bid Price 0.0268
Ask Price 0.03
News -
Day High 0.0269


52 Week Range


Day Low 0.02
Company Name Stock Ticker Symbol Market Type
Mymetics Corporation (QB) MYMX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00005 -0.19% 0.02685 16:00:27
Open Price Low Price High Price Close Price Prev Close
0.02595 0.02 0.0269 0.02685 0.0269
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
69 300,900 $ 0.024357 $ 7,329 - 0.019 - 0.115
Last Trade Time Type Quantity Stock Price Currency
15:51:26 9,800 $ 0.02685 USD


Draw Mode:

Mymetics Corporation (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.16M 303.76M 80.39M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
20.45k $ - - - -

more financials information »

Mymetics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYMX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0264250.02690.020.02643795,1400.000421.61%
1 Month0.0190.030.0190.02382542,3790.0078541.32%
3 Months0.04190.04430.0190.02855568,929-0.01505-35.92%
6 Months0.0480.0590.0190.035900759,301-0.02115-44.06%
1 Year0.03250.1150.0190.056964695,755-0.00565-17.38%
3 Years0.0333250.190.0190.0729685138,022-0.00648-19.43%
5 Years0.023040.190.0190.0621552127,9100.0038116.54%

Mymetics (QB) Description

Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation vaccines for infectious and life threatening diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins. Mymetics currently has the following vaccines in its pipeline: HIV/AIDS and Covid-19 and collaboration projects in the cancer immunotherapy field.